pilocarpine hydrochloride · Sandoz · NDA 200890
Isopto Carpine
Earliest generic entry, as listed · earliest of 3 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- 25 Oct 2026Generic approved · 200890-0012 Oct 2025
Products covered · 3
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 200890 · 001 · RLD | solution/drops, ophthalmic | 1% | open |
| 200890 · 002 · RLD | solution/drops, ophthalmic | 2% | open |
| 200890 · 003 · RLD | solution/drops, ophthalmic | 4% | open |